US Stock MarketDetailed Quotes
AUTL Autolus Therapeutics
- 4.000
- -0.080-1.96%
Close Apr 26 16:00 ET
1.06BMarket Cap-3333P/E (TTM)
4.145High3.990Low2.75MVolume4.090Open4.080Pre Close11.16MTurnover3.01%Turnover RatioLossP/E (Static)265.93MShares7.45052wk High9.55P/B364.70MFloat Cap1.79052wk Low--Dividend TTM91.18MShs Float53.240Historical High--Div YieldTTM3.80%Amplitude1.600Historical Low4.065Avg Price1Lot Size
Autolus Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -29.63%-145.59M | -70.49%-24.83M | -25.97%-40.19M | -23.82%-38.15M | -21.09%-42.42M | 4.71%-112.31M | -59.05%-14.57M | 8.19%-31.9M | 15.85%-30.81M | 6.19%-35.03M |
| Net income from continuing operations | -40.01%-208.38M | -186.34%-77.17M | -7.20%-45.85M | -8.31%-45.55M | -7.42%-39.81M | -4.75%-148.84M | 35.32%-26.95M | -25.83%-42.77M | -26.78%-42.06M | -11.41%-37.06M |
| Operating gains losses | -184.53%-3.81M | -20.46%-7.26M | 11.73%5.92M | ---3.28M | --804K | 571.28%4.51M | ---6.03M | --5.3M | ---- | ---- |
| Depreciation and amortization | -11.55%6.57M | 7.64%1.78M | -22.83%1.38M | -21.21%1.51M | -8.13%1.9M | -12.25%7.42M | -21.63%1.65M | -27.00%1.79M | -14.48%1.92M | 24.37%2.07M |
| Deferred tax | -267.91%-986K | -246.08%-466K | -48.75%-238K | 65.61%-87K | -12.07%-195K | -272.22%-268K | 175.95%319K | -168.67%-160K | -164.05%-253K | 37.86%-174K |
| Other non cash items | 299.09%49.15M | 396.14%34.18M | 174.29%5.01M | 174.13%4.96M | 179.33%5M | 154.99%12.32M | 42.98%6.89M | 182,700.00%1.83M | --1.81M | 16,172.73%1.79M |
| Change In working capital | -45.52%292K | 239.37%20.83M | -688.64%-9.65M | 521.39%1.64M | -213.81%-12.52M | 30.73%536K | -66.23%6.14M | 75.24%-1.22M | 94.73%-388K | 27.07%-3.99M |
| -Change in prepaid assets | 223.62%13.36M | 86.92%18.14M | 52.56%-5.06M | 194.03%4.32M | 23.01%-4.04M | -262.45%-10.81M | -65.62%9.71M | 18.63%-10.67M | -4.58%-4.59M | -28.78%-5.25M |
| -Change in payables and accrued expense | -96.95%489K | 1,019.47%7.24M | -105.08%-487K | -75.72%1.02M | -550.12%-7.28M | 517.75%16.03M | 110.90%647K | 25.29%9.58M | 183.98%4.18M | 386.88%1.62M |
| -Change in other current liabilities | -189.20%-13.56M | ---- | ---- | ---- | ---- | -94.89%-4.69M | ---- | ---- | ---- | ---- |
| -Change in other working capital | ---- | ---- | -3,008.33%-4.1M | -18,595.00%-3.7M | -233.33%-1.2M | ---- | ---- | ---132K | --20K | ---360K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -29.63%-145.59M | -70.49%-24.83M | -25.97%-40.19M | -23.82%-38.15M | -21.09%-42.42M | 4.71%-112.31M | -59.05%-14.57M | 8.19%-31.9M | 15.85%-30.81M | 6.19%-35.03M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1.34%-10.99M | -133.33%-1.48M | 77.96%-1.5M | -66.25%-4.39M | -369.78%-3.62M | -22.40%-10.84M | 60.06%-633K | -76.04%-6.8M | -74.72%-2.64M | 59.42%-771K |
| Net PPE purchase and sale | -1.34%-10.99M | -133.33%-1.48M | 77.96%-1.5M | -66.25%-4.39M | -369.78%-3.62M | -22.40%-10.84M | 60.06%-633K | -76.04%-6.8M | -74.72%-2.64M | 59.42%-771K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1.34%-10.99M | -133.33%-1.48M | 77.96%-1.5M | -66.25%-4.39M | -369.78%-3.62M | -22.40%-10.84M | 60.06%-633K | -76.04%-6.8M | -74.72%-2.64M | 59.42%-771K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.39%-883K | -99.99%23K | -96.08%4K | -219K | -69,000.00%-691K | -21.28%223.61M | 51.62%223.51M | 144.35%102K | 0 | -100.00%-1K |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | -33.37%163.85M | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -76.92%27K | --23K | ---- | ---- | ---- | -6.40%117K | --0 | ---- | ---- | ---- |
| Net other financing activities | -101.53%-910K | --0 | --0 | ---219K | -69,000.00%-691K | 56.79%59.64M | --59.66M | ---15K | --0 | 99.99%-1K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.39%-883K | -99.99%23K | -96.08%4K | ---219K | -69,000.00%-691K | -21.28%223.61M | 51.62%223.51M | 144.35%102K | --0 | -100.00%-1K |
| Net cash flow | ||||||||||
| Beginning cash position | 23.20%382.76M | 57.22%256.85M | 42.01%307.83M | 27.69%343.36M | 23.20%382.76M | 101.63%310.68M | -5.71%163.37M | 0.09%216.76M | 12.13%268.89M | 101.63%310.68M |
| Current changes in cash | -256.73%-157.46M | -112.62%-26.29M | -7.99%-41.68M | -27.83%-42.76M | -30.53%-46.73M | -36.15%100.46M | 52.42%208.31M | 0.62%-38.6M | -36.14%-33.45M | -142.58%-35.8M |
| Effect of exchange rate changes | 152.97%15.03M | -11.82%9.77M | 37.13%-9.3M | 138.71%7.23M | 222.47%7.33M | -3,663.40%-28.38M | 1,409.95%11.08M | -232.32%-14.8M | -1,502.55%-18.68M | -466.54%-5.98M |
| End cash Position | -37.21%240.34M | -37.21%240.34M | 57.22%256.85M | 42.01%307.83M | 27.69%343.36M | 23.20%382.76M | 23.20%382.76M | -5.71%163.37M | 0.09%216.76M | 12.13%268.89M |
| Free cash flow | -27.14%-156.57M | -73.10%-26.31M | -7.71%-41.69M | -27.17%-42.54M | -28.60%-46.04M | 2.82%-123.15M | -41.48%-15.2M | -0.24%-38.7M | 12.26%-33.45M | 8.77%-35.8M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg